KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Asset Utilization Ratio (2016 - 2025)

Pacific Biosciences Of California has reported Asset Utilization Ratio over the past 15 years, most recently at 0.2 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.2 for Q4 2025, up 77.41% from a year ago — trailing twelve months through Dec 2025 was 0.2 (up 77.41% YoY), and the annual figure for FY2025 was 0.16, up 52.77%.
  • Asset Utilization Ratio for Q4 2025 was 0.2 at Pacific Biosciences Of California, up from 0.19 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for PACB hit a ceiling of 0.2 in Q4 2025 and a floor of 0.05 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.11 (2021), compared with a mean of 0.11.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 76.99% in 2021 and later skyrocketed 77.41% in 2025.
  • Pacific Biosciences Of California's Asset Utilization Ratio stood at 0.08 in 2021, then dropped by 15.52% to 0.07 in 2022, then surged by 53.78% to 0.11 in 2023, then increased by 3.27% to 0.11 in 2024, then surged by 77.41% to 0.2 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.2 (Q4 2025), 0.19 (Q3 2025), and 0.19 (Q2 2025) per Business Quant data.